Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Des Devel Ther ; 15: 2843-2855, 2021.
Article in English | MEDLINE | ID: mdl-34234415

ABSTRACT

PURPOSE: A novel folate receptor-targeted ß-cyclodextrin (ß-CD) drug delivery vehicle was constructed to improve the bioavailability, biosafety, and drug loading capacity of curcumin. Controlled release and targeted delivery was achieved by modifying the nanoparticles with folic acid (FA). METHODS: Folate-conjugated ß-CD-polycaprolactone block copolymers were synthesized and characterized. Curcumin-loaded nanoparticles (FA-Cur-NPs) were structured by self-assembly. The physicochemical properties, stability, release behavior and tumor-targeting ability of the fabricated nanoparticles were studied. RESULTS: The average particle size and drug loading of FA-Cur-NPs was 151.8 nm and 20.27%, respectively. Moreover, the FA-Cur-NPs exhibited good stability in vitro for 72 h. The drug release profiles showed that curcumin from FA-Cur-NPs was released significantly faster in a pH 6.4 phosphate buffered solution (PBS) than in pH 7.4, indicating that curcumin can be enriched around the tumor site compared with normal cells. Additionally, the internalization of FA-Cur-NPs was aided by FA receptor-mediated endocytosis, and its cytotoxicity was proportional to the cellular uptake efficiency. Furthermore, in vivo studies confirmed that FA-Cur-NPs exhibited marked accumulation in the tumor site and excellent antitumor activity. CONCLUSION: These findings suggest that FA-Cur-NPs are a promising approach for improving cancer therapy through active targeting and controllable release.


Subject(s)
Curcumin/administration & dosage , Drug Delivery Systems , Folic Acid/administration & dosage , Nanoparticles , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/pharmacology , Curcumin/pharmacokinetics , Curcumin/pharmacology , Drug Carriers/chemistry , Drug Liberation , Female , Folate Receptors, GPI-Anchored/metabolism , Folic Acid/pharmacokinetics , Folic Acid/pharmacology , HeLa Cells , Humans , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasms/drug therapy , Particle Size , Polyesters/chemistry , Tissue Distribution , Xenograft Model Antitumor Assays , beta-Cyclodextrins/chemistry
2.
Int J Nanomedicine ; 14: 4683-4695, 2019.
Article in English | MEDLINE | ID: mdl-31308653

ABSTRACT

Purpose: Clinical applications of curcumin (Cur) have been greatly restricted due to its low solubility and poor systemic bioavailability. Three-arm amphiphilic copolymer tricarballylic acid-poly (ε-caprolactone)-methoxypolyethylene glycol (Tri-CL-mPEG) nanoparticles (NPs) were designed to improve the solubility and bioavailability of Cur. The present study adopted a microchannel system to precisely control the preparation of self-assembly polymeric NPs via liquid flow-focusing and gas displacing method. Methods: The amphiphilic three-arm copolymer Tri-CL-mPEG was synthesized and self-assembled into nearly spherical NPs, yielding Cur encapsulated into NP cores (Cur-NPs). The obtained NPs were evaluated for physicochemical properties, morphology, toxicity, cellular uptake by A549 cells, release in vitro, biodistribution, and pharmacokinetics in vivo. Results: Rapidly fabricated and isodispersed Cur-NPs prepared by this method had an average diameter of 116±3 nm and a polydispersity index of 0.197±0.008. The drug loading capacity and entrapment efficiency of Cur-NPs were 5.58±0.23% and 91.42±0.39%, respectively. In vitro release experiments showed sustained release of Cur, with cumulative release values of 40.1% and 66.1% at pH 7.4 and pH 5.0, respectively, after 10 days post-incubation. The results of cellular uptake, biodistribution, and in vivo pharmacokinetics experiments demonstrated that Cur-NPs exhibited better biocompatibility and bioavailability, while additionally enabling greater cellular uptake and prolonged circulation with possible spleen, lung, and kidney targeting effects when compared to the properties of free Cur. Conclusion: These results indicate that Tri-CL-mPEG NPs are promising in clinical applications as a controllable delivery system for hydrophobic drugs.


Subject(s)
Curcumin/pharmacology , Microfluidics/methods , Nanoparticles/chemistry , Polyethylene Glycols/chemistry , Polymers/chemistry , Tricarboxylic Acids/chemistry , A549 Cells , Animals , Cell Proliferation/drug effects , Cell Survival/drug effects , Curcumin/chemistry , Curcumin/pharmacokinetics , Drug Liberation , Endocytosis/drug effects , Humans , Mice , Molecular Weight , Nanoparticles/ultrastructure , Particle Size , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Rats, Sprague-Dawley , Tissue Distribution/drug effects
3.
J Nanobiotechnology ; 16(1): 57, 2018 Jul 16.
Article in English | MEDLINE | ID: mdl-30012166

ABSTRACT

BACKGROUND: Matrix-metalloproteinases, which are overexpressed in many types of cancer, can be applied to improve the bioavailability of chemotherapeutic drugs and guide therapeutic targeting. Thus, we aimed to develop enzyme-responsive nanoparticles based on a functionalized copolymer (mPEG-Peptide-PCL), which was sensitive to matrix metalloproteinase, as smart drug vesicles for enhanced biological specificity and reduced side effects. RESULTS: The rate of in vitro curcumin (Cur) release from Cur-P-NPs was not markedly accelerated in weakly acidic tumor microenvironment, indicating a stable intracellular concentration and a consistent therapeutic effect. Meanwhile, P-NPs and Cur-P-NPs displayed prominent biocompatibility, biostability, and inhibition efficiency in tumor cells. In addition, Cur-P-NPs showed higher fluorescence intensity than Cur-NPs in tumor cells, implying enhanced cell permeability and targeting ability. Moreover, the internalization and intracellular transport of Cur-P-NPs were mainly via macropinocytosis. Studies of pharmacodynamics and cellular uptake in vitro and biodistribution in vivo demonstrated that Cur-P-NPs had stronger target efficiency and therapeutic effect than Cur-DMSO and Cur-NPs in tumor tissue. CONCLUSION: Results indicate that Cur-P-NPs can be employed for active targeted drug delivery in cancer treatment and other biomedical applications.


Subject(s)
Antineoplastic Agents/chemistry , Lung Neoplasms/drug therapy , Matrix Metalloproteinases/metabolism , Nanoparticles/chemistry , Animals , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Biological Availability , Cell Line, Tumor , Cell Survival/drug effects , Cell-Penetrating Peptides/chemistry , Curcumin/chemistry , Curcumin/pharmacology , Curcumin/therapeutic use , Drug Carriers , Drug Liberation , Humans , Lung Neoplasms/metabolism , Mice, Nude , Molecular Targeted Therapy , Nanoparticles/therapeutic use , Particle Size , Polyesters/chemistry , Polyethylene Glycols/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...